Announcements and Notices - [Other - Business Update]

Immunotech Biopharm Ltd operates as a biopharmaceutical company. The Company develops and produces cellular immunotherapy products and other products. Immunotech Biopharm markets its products throughout China.

Voluntary Announcement
Car-T-19 Injection Was Granted Breakthrough
Therapy Designation

Announcements and Notices - [Change in Company Secretary]

Resignation Of Joint Company Secretary And Change Of Authorised Representative

Update On Contractual Arrangements

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024 Interim Report

Announcements and Notices - [Interim Results]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Immunotech Biopharm (6978 HK)

Voluntary Announcement Car-T-19 Injection Was Granted Breakthrough Therapy Designation

Resignation Of Joint Company Secretary And Change Of Authorised Representative

Update On Contractual Arrangements

2024 Interim Report

Announcement Of The Interim Results For The Six Months Ended 30 June 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)